LexaGene Holdings (TSX.V: LXG) (OTCQB: LXXGF), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, has sold another of its exclusive MiQLab(TM) Systems. The Alpine Veterinary Hospital in Concord, California, purchased the system; the new sale comes on the heels of exciting sales news last week that indicates enthusiastic interest in the company’s game-changing diagnostic system. The company also announced that LXXGF founder and CEO Dr. Jack Regan will be presenting at several upcoming conferences. Those conferences include the Lytham Partners Summer 2021 Investor Conference, scheduled for June 14-16, 2021; LexaGene executives will also participate in one-on-one meetings throughout the event. Regan’s presentation is scheduled for June 14. Regan will also be presenting as part of the Microfluidic Hotseat at the Annual Microfluids Consortium, which is hosted by the Centre for Business Innovation. This event is scheduled for Tuesday, June 15. In addition, Regan will be a featured speaker at the 28th annual International Biothreat and Pathogen Detection Conference, which is scheduled for Thursday, June 17. His presentation will discuss how easily the MiQLab can be configured to detect multiple pathogens in a single sample as a critical measure in biosurveillance activities. “Following up on last weeks’ sales news, I’m pleased to report we have sold another MiQLab System,” said LexaGene CEO and founder Dr. Jack Regan in the press release. “Alpine Veterinary Hospital, led by Dr. Virk, provides a wide range of services including emergency and orthopedic surgeries in the Bay Area of California. Dr. Virk is a passionate proponent of antimicrobial stewardship and is committed to providing the best animal care through diagnostics. He believes the MiQLab System offers the best solution for his hospital. We are excited that Alpine Veterinary Hospital sees that the future of animal care begins with the MiQLab System. We continue to gain momentum in veterinary health as we’ve generated multiple MiQLab sale leads from ACVIM Forum, which we attended last week, and from the hard work of our dedicated sales team.”
To view the full press release, visit
https://ibn.fm/vXWFV
About LexaGene Holdings Inc.
LexaGene is a molecular diagnostics company that develops molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for onsite rapid testing in veterinary diagnostics and food safety, and for use in open-access markets such as clinical research, agricultural testing and biodefense. End users simply need to collect a sample, load the sample onto the instrument with a sample preparation cartridge, enter the sample ID and press go. LexaGene’s MiQLab(TM) system delivers excellent sensitivity, specificity and breadth of detection, and can return results in approximately two hours. The unique open-access feature is designed for custom testing so that end users can load their own real-time PCR assays onto the instrument to target any genetic target of interest. For more information about the company, visit
www.LexaGene.com.
NOTE TO INVESTORS: The latest news and updates relating to LXXGF are available in the company’s newsroom at
https://ibn.fm/LXXGF
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.